CM&D Pharma Report issue

For profit Phase 2
Founded: Lutry Switzerland (2007)
Status: Acquired by Nestle (2011)

Organization Overview

First Clinical Trial
2009
NCT01402648
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CM&D Pharma Limited | MARIA CRISTINA COMELLI

Active Ingredients

Drugs in Phase 2 Trials (4)

eviendep (1 trial)

maltodextrin (1 trial)

palmitoylethanolamide (1 trial)

polydotin peceid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Hyperalgesia (Phase 2)

Inflammation (Phase 2)

Irritable Bowel Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4